PEN Y BONT SURGERY
THE ROE, ST. ASAPH
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 15 | 18 | 83.3% | |
| HF 4 | 2011 | 13 | 15 | 86.7% | |
| HF 4 | 2012 | 29 | 34 | 85.3% | |
| HF 4 | 2013 | 29 | 30 | 96.7% | |
| HF004W | 2014 | 32 | 38 | 84.2% | |
| HF004 | 2015 | 32 | 37 | 86.5% |
